On July 11, 2022, Velan Capital Investment Management LP and Repertoire Partners LP announced that while it believes that the proposed sale to Gurnet Point Capital and Patient Square Capital does not reflect the full price of the Company and its assets, it pleased that its involvement drove an outcome that ultimately should allow stockholders to recoup a portion of the value that has been lost under the Company' current Board of Directors. Velan Capital stated that as a result, it is withdrawing its director nominations. Velan Capital stated that it is grateful to its exceptionally qualified director candidates Eric Ende, Cynthia Flowers, and Ann MacDougall for their time, expertise, and dedication to improving the Radius Board of Directors.

In addition, it would also like to thank the fellow stockholders who supported us and its nominees both privately and publicly.